Comprehensive clinical characteristics of hospitalized patients with mid-range left ventricular ejection fraction

Abstract

Get full access to this article

View all access options for this article.

References

Ponikowski

Voors

Anker

, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200.

Jorgensen

Andersson

Vasan

, et al. Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: A systematic review and meta-analyses. Eur J Prev Cardiol 2018; 25: 366–376.

Sato

Yoshihisa

Kanno

, et al. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction. Eur J Prev Cardiol 2017; 24: 1979–1987.

Chioncel O, Mebazaa A, Maggioni AP, et al. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. Epub ahead of print 28 May 2019. DOI: 10.1002/ejhf.1492.

Cho

Choe

Cho

, et al. Comparison of characteristics and 3-year outcomes in patients with acute heart failure with preserved, mid-range, and reduced ejection fraction. Circ J 2019; 83: 347–356.

Altaie

Khalife

. The prognosis of mid-range ejection fraction heart failure: A systematic review and meta-analysis. ESC Heart Fail 2018; 5: 1008–1016.

Bhambhani

Kizer

Lima

JAC

, et al. Predictors and outcomes of heart failure with mid-range ejection fraction. Eur J Heart Fail 2018; 20: 651–659.

Koh

Tay

Teng

THK

, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 2017; 19: 1624–1634.

McMurray

Adamopoulos

Anker

, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803–869.

10.

Yoshihisa

Kimishima

Kiko

, et al. Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension. Int J Cardiol, 258, 2018, pp. 269–274.